Multi-omics

Liver infected with hepatitis. Illustration: depositphotos.com

When the virus leaves a mark: Epigenetic “stamp” after hepatitis C cure may explain ongoing risk of liver cancer

Research led by Prof. Meital Gal-Tanaami of Bar-Ilan University and supported by the Israel Science Foundation is examining how a virus that remains in the cytoplasm manages to change genetic control in the nucleus, and is attempting to map points of intervention to reduce cancer risk as well.